A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
米拉地美坦 (DS3032b) 联合低剂量阿糖胞苷（加或不加维奈托克）治疗急性髓系白血病的 I 期研究：临床安全性、有效性和相关性分析
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00871-1
Senapati, Jayastu; Muftuoglu, Muharrem; Ishizawa, Jo; Abbas, Hussein A; Loghavi, Sanam; Borthakur, Gautam; Yilmaz, Musa; Issa, Ghayas C; Dara, Samuel I; Basyal, Mahesh; Li, Li; Naqvi, Kiran; Pourebrahim, Rasoul; Jabbour, Elias J; Kornblau, Steven M; Short, Nicholas J; Pemmaraju, Naveen; Garcia-Manero, Guillermo; Ravandi, Farhad; Khoury, Joseph; Daver, Naval; Kantarjian, Hagop M; Andreeff, Michael; DiNardo, Courtney D
